Guided Therapeutics, Inc. (GTHP)
OTCMKTS: GTHP · Delayed Price · USD
0.139
-0.001 (-0.64%)
Jul 23, 2024, 4:00 PM EDT - Market closed
Guided Therapeutics Revenue
Guided Therapeutics had revenue of $82.00K in the twelve months ending March 31, 2024, with 105.00% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $6.00K. In the year 2023, Guided Therapeutics had annual revenue of $98.00K with 653.85% growth.
Revenue (ttm)
$82.00K
Revenue Growth
+105.00%
P/S Ratio
95.00
Revenue / Employee
$20,500
Employees
4
Market Cap
7.74M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 98.00K | 85.00K | 653.85% |
Dec 31, 2022 | 13.00K | -68.00K | -83.95% |
Dec 31, 2021 | 81.00K | -21.00K | -20.59% |
Dec 31, 2020 | 102.00K | 66.00K | 183.33% |
Dec 31, 2019 | 36.00K | -21.00K | -36.84% |
Dec 31, 2018 | 57.00K | -187.00K | -76.64% |
Dec 31, 2017 | 244.00K | -361.00K | -59.67% |
Dec 31, 2016 | 605.00K | -1.00K | -0.17% |
Dec 31, 2015 | 606.00K | -217.00K | -26.37% |
Dec 31, 2014 | 823.00K | -356.00K | -30.20% |
Dec 31, 2013 | 1.18M | -2.23M | -65.43% |
Dec 31, 2012 | 3.41M | -187.00K | -5.20% |
Dec 31, 2011 | 3.60M | 233.00K | 6.93% |
Dec 31, 2010 | 3.36M | 1.81M | 117.03% |
Dec 31, 2009 | 1.55M | 233.00K | 17.69% |
Dec 31, 2008 | 1.32M | 280.00K | 27.00% |
Dec 31, 2007 | 1.04M | 60.00K | 6.14% |
Dec 31, 2006 | 977.00K | -6.00K | -0.61% |
Dec 31, 2005 | 983.00K | -90.00K | -8.39% |
Dec 31, 2004 | 1.07M | -513.00K | -32.35% |
Dec 31, 2003 | 1.59M | -2.21M | -58.24% |
Dec 31, 2002 | 3.80M | 1.34M | 54.52% |
Dec 31, 2001 | 2.46M | -2.51M | -50.52% |
Dec 31, 2000 | 4.97M | 1.67M | 50.55% |
Dec 31, 1999 | 3.30M | 1.90M | 135.71% |
Dec 31, 1998 | 1.40M | 500.00K | 55.56% |
Dec 31, 1997 | 900.00K | 400.00K | 80.00% |
Dec 31, 1996 | 500.00K | -680.00K | -57.63% |
Dec 31, 1995 | 1.18M | 1.06M | 883.33% |
Dec 31, 1994 | 120.00K | - | - |
Dec 31, 1993 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 379.49B |
Johnson & Johnson | 81.80B |
Merck & Co. | 61.40B |
AbbVie | 54.40B |
Novartis AG | 48.86B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.49B |
Eli Lilly | 35.93B |
GTHP News
- 13 days ago - Guided Therapeutics' Announces Data from Chinese NMPA Clinical Study Signed Off by All Four Clinical Sites With Better Than Expected Results - Business Wire
- 5 months ago - Leading Cervical Cancer Doctors Support Approval of LuViva in China Based on Preliminary Review of Clinical Trial Results - Business Wire
- 8 months ago - Guided Therapeutics Announces Completion of Clinical Study for Chinese Regulatory Approval - Business Wire